JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2026, 75(1):35-41 | DOI: 10.36290/csf.2026.007

Pelargonium sidoides DC. vs. Pelargonium reniforme (Andrews) Curtis -active constituents and medicinal effects

Zdeňka Navrátilová
Přírodovědecká fakulta UK, katedra botaniky, Praha

Pelargonium sidoides and Pelargonium reniforme are two closely related species of geraniums growing in Southern Africa. The species belong to the section Reniformia and are morphologically quite similar and often confused. Both species are used for medicinal purposes, but differ in the representation of the compounds and pharmacological effects. The article summarizes information about their composition and medicinal effects and compare it.

Keywords: Pelargonium sidoides, Pelargonium reniforme, Pelargonii radix, EPs 7630, Umckaloabo, bronchitis, cold.

Accepted: February 19, 2026; Published: March 13, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Navrátilová Z. Pelargonium sidoides DC. vs. Pelargonium reniforme (Andrews) Curtis -active constituents and medicinal effects. Čes. slov. farm. 2026;75(1):35-41. doi: 10.36290/csf.2026.007.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Purchase PDF - 60 CZK (2.5 EUR)
    will be unlocked 13.3.2027

    References

    1. Kolodziej H. Fascinating metabolic pools of Pelargonium sidoides and Pelargonium reniforme, traditional and phytomedicinal sources of the herbal medicine Umckaloabo®. Phytomedicine 2007;14:9-17. Go to original source... Go to PubMed...
    2. Kolodziej H. Pelargonium reniforme and Pelargonium sidoides: their botany, chemistry and medicinal use. In: Lis-Balchin M (ed.). Geranium and Pelargonium. Medicinal and Aromatic Plants - Industrial Profiles. London, New York: Taylor & Francis; 2002. pp. 262-90.
    3. EMA (European Medicines Agency), Committee on Herbal Medicinal Products. Assessment report on Pelargonium sidoides DC and/or Pelargonium reniforme Curt., radix. EMA/HMPC/444251/2015.
    4. Bladt S, Wagner H. From the Zulu medicine to the European phytomedicine Umckaloabo. Phytomedicine. 2007;14(Suppl 6):2-4. Go to original source... Go to PubMed...
    5. Brendler T, van Wyk BE. A historical, scientific and commercial perspective on the medicinal use of Pelargonium sidoides (Geraniaceae). J Ethnopharmacol. 2008;119(3):420-33. Go to original source... Go to PubMed...
    6. Navrátilová Z. Léčivý muškát Pelargonium sidoides. Prakt lékáren. 2012;8(6):290-2.
    7. Kolektiv autorů. Český lékopis 2023. Praha: Grada; 2023. pp. 5666-8.
    8. Dreyer LL, Marais EM. Section Reniformia, a new section in the genus Pelargonium (Geraniaceae). S Afr J Bot 2000;66(1):44-51. Go to original source...
    9. Eggli U, Nyffeler R (eds.). Dicotyledons: Rosids. Illustrated Handbook of Succulent Plants. 2nd ed. Switzerland AG: Springer Nature; 2023. Go to original source...
    10. Jahodář L. Farmaceuticky významné semenné rostliny. Praha: Karolinum; 2022.
    11. Maree JE, Viljoen AM. Phytochemical distinction between Pelargonium sidoides and Pelargonium reniforme - A quality control perspective. South Afr J Bot. 2012;82:83-91. Go to original source...
    12. Viljoen AM, Zhao J, Sandasi M, et al. Phytochemical distinction between Pelargonium sidoides (''Umckaloabo'') and P. reniforme through 1H-NMR and UHPLC-MS metabolomic profiling. Metabolomics. 2015;11:594-602. Go to original source...
    13. Kayser O, Kolodziej H. Antibacterial activity of extracts and constituents of Pelargonium sidoides and Pelargonium reniforme. Planta Med. 1997;63(6):508-10. Go to original source... Go to PubMed...
    14. Kolodziej H, Kiderlen AF. In vitro evaluation of antibacterial and immunomodulatory activities of Pelargonium reniforme, Pelargonium sidoides and the related herbal drug preparation EPs® 7630. Phytomedicine. 2007;14:18-26. Go to original source... Go to PubMed...
    15. Mativandlela SPN, Lall N, Meyer JJM. Antibacterial, antifungal and antitubercular activity of (the roots of) Pelargonium reniforme (CURT) and Pelargonium sidoides (DC) (Geraniaceae) root extracts. South Afr J Bot. 2006;72:232-7. Go to original source...
    16. Papies J, Emanuel J, Heinemann N. Antiviral and immunomodulatory effects of Pelargonium sidoides DC. root extract EPs® 7630 in SARS-CoV-2-infected human lung cells. Front Pharmacol. 2021;12:757666. Go to original source... Go to PubMed...
    17. Emanuel J, Papies J, Galander C. In vitro and in vivo effects of Pelargonium sidoides DC. root extract EPs® 7630 and selected constituents against SARS-CoV-2 B.1, Delta AY.4/ AY.117 and Omicron BA.2. Front Pharmacol. 2023;14:1214351. Go to original source... Go to PubMed...
    18. Cinatl J Jr, Wass MN, Michaelis M. Multiple mechanisms enable broad-spectrum activity of the Pelargonium sidoides root extract EPs 7630 against acute respiratory tract infections. Front Pharmacol. 2024;15:1455870. Go to original source... Go to PubMed...
    19. Agbabiaka TB, Gao R, Ernst E. Pelargonium sidoides for acute bronchitis: a systematic review and meta-analysis. Phytomedicine. 2008;15(5):378-85. Go to original source... Go to PubMed...
    20. Careddu D, Pettenazzu A. Pelargonium sidoides extract EPs 7630: a review of its clinical efficacy and safety for treating acute respiratory tract infections in children. Int J Gen Med. 2018;11:91-8. Go to original source... Go to PubMed...
    21. Bachert C, Schapoval A, Funk P. Treatment of acute rhinosinusitis with the preparation from Pelargonium sidoides EPs 7630: a randomized, double-blind, placebo-controlled trial. Rhinology. 2009;47(1):51-8.
    22. Gökçe Ş, Dörtkardeşler BE, Yurtseven A, et al. Effectiveness of Pelargonium sidoides in pediatric patients diagnosed with uncomplicated upper respiratory tract infection: a single-blind, randomized, placebo-controlled study. Eur J Pediatr. 2021;180(9):3019-28. Go to original source... Go to PubMed...
    23. Willcox M, Simpson C, Wilding S, et al. Pelargonium sidoides root extract for the treatment of acute cough due to lower respiratory tract infection in adults: a feasibility double-blind, placebo-controlled randomised trial. BMC Complement Med Ther. 2021;21(1):48. Go to original source... Go to PubMed...
    24. Tahan F, Yaman M. Can the Pelargonium sidoides root extract EPs 7630 prevent asth­ma attacks during viral infections of the upper respiratory tract in children? Phytomedicine. 2013;20(2):148-50. Go to original source... Go to PubMed...
    25. Matthys H, Funk P. Pelargonium sidoides preparation EPs 7630 in COPD: health-related quality-of-life and other patient-reported outcomes in adults receiving add-on therapy. Curr Med Res Opin. 2018;34(7):1245-51. Go to original source... Go to PubMed...
    26. SPC přípravku Kaloba. www.sukl.cz (11. 12. 2025).
    27. https://www.umckaloabo-stiftung.de/de (10. 12. 2025).

    Return to the content


    Czech and Slovak Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.